Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2

Cell Death and Disease

Volumn 4, Issue 4, 2013, Pages

  Kim, J H ^a,b   Park, S G ^a   Song, S Y ^a   Kim, J K ^a   Sung, J H ^a,b  

^a CHA University   (South Korea)

^b CHA Stem Cell Institute   (South Korea)

Author keywords

Adipose derived stem cell; Elk1; MiR 210; NF B; PTPN2; Reactive oxygen species

Indexed keywords

CITRININ; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON SULFUR CLUSTER SCAFFOLD HOMOLOG 1; IRON SULFUR CLUSTER SCAFFOLD HOMOLOG 2; LUCIFERASE; MICRORNA 210; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; ROTENONE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG; ANTIMYCIN A1; DRUG DERIVATIVE; ELK1 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; MICRORNA; MIRN210 MICRORNA, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; PTPN2 PROTEIN, HUMAN; IRON SULFUR PROTEIN; PLATELET DERIVED GROWTH FACTOR;

ADIPOSE DERIVED STEM CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ADIPOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL HYPOXIA; CELL MOTION; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SIGNAL TRANSDUCTION; STEM CELL; GENE EXPRESSION; GENE TARGETING;

ADIPOCYTES; ANTIMYCIN A; CELL DIFFERENTIATION; CELL HYPOXIA; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ETS-DOMAIN PROTEIN ELK-1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICRORNAS; NF-KAPPA B; OXYGEN; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-SIS; REACTIVE OXYGEN SPECIES; ROTENONE; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84876947528     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.117     Document Type: Article

References (54)

1. Gehring WJ, Hiromi Y. Homeotic genes and the homeobox. Annu Rev Genet 1986; 20: 147-173
2. Bel-Vialar S, Itasaki N, Krumlauf R. Initiating Hox gene expression: In the early chick neural tube differential sensitivity to FGF and RA signaling subdivides the HoxB genes in two distinct groups. Development 2002; 129: 5103-5115
3. Nordstrom U, Maier E, Jessell TM, Edlund T. An early role for WNT signaling in specifying neural patterns of Cdx and Hox gene expression and motor neuron subtype identity. PLoS Biol 2006; 4: E252
4. Daniels TR, Neacato II, Rodriguez JA, Pandha HS, Morgan R, Penichet ML. Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells. Leukemia 2010; 24: 1555-1565
5. Shears L, Plowright L, Harrington K, Pandha HS, Morgan R. Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P. J Urol 2008; 180: 2196-2201
6. Plowright L, Harrington KJ, Pandha HS, Morgan R. HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Br J Cancer 2009; 100: 470-475
7. Abate-Shen C. Deregulated homeobox gene expression in cancer: Cause or consequence? Nat Rev Cancer 2002; 2: 777-785
8. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B. Terminology and morphologic criteria of neuroblastic tumors: Recommendations by the International Neuroblastoma Pathology Committee. Cancer 1999; 86: 349-363
9. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 1993; 328: 847-854
10. van Noesel MM. Neuroblastoma stage 4S: A multifocal stem-cell disease of the developing neural crest. Lancet Oncol Mar 2012; 13: 229-230
11. Pritchard J, Hickman JA. Why does stage 4s neuroblastoma regress spontaneously? Lancet 1994; 344: 869-870
12. Nakagawara A. Neural crest development and neuroblastoma: The genetic and biological link. Prog Brain Res 2004; 146: 233-242
13. Nakagawara A, Ohira M. Comprehensive genomics linking between neural development and cancer: Neuroblastoma as a model. Cancer Lett 2004; 204: 213-224
14. Fischer M, Oberthuer A, Brors B, Kahlert Y, Skowron M, Voth H et al. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome. Clin Cancer Res 2006; 12: 5118-5128
15. Mosse YP, Laudenslager M, Khazi D, Carlisle AJ, Winter CL, Rappaport E et al. Germline PHOX2B mutation in hereditary neuroblastoma. Am J Hum Genet 2004; 75: 727-730
16. Pattyn A, Morin X, Cremer H, Goridis C, Brunet JF. The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature 1999; 399: 366-370
17. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 1983; 305: 245-248
18. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985; 313: 1111-1116
19. Alaminos M, Mora J, Cheung NK, Smith A, Qin J, Chen L et al. Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. Cancer Res 2003; 63: 4538-4546
20. Manohar CF, Furtado MR, Salwen HR, Cohn SL. Hox gene expression in differentiating human neuroblastoma cells. Biochem Mol Biol Int 1993; 30: 733-741
21. Mao L, Ding J, Zha Y, Yang L, McCarthy BA, King W et al. HOXC9 links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma. Cancer Res 2011; 71: 4314-4324
22. Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R et al. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol 2006; 24: 5070-5078
23. Oberthuer A, Hero B, Berthold F, Juraeva D, Faldum A, Kahlert Y et al. Prognostic impact of gene expression-based classification for neuroblastoma. J Clin Oncol 2010; 28: 3506-3515
24. Hughes M, Marsden HB, Palmer MK. Histologic patterns of neuroblastoma related to prognosis and clinical staging. Cancer 1974; 34: 1706-1711
25. Shimada H, Chatten J, Newton WA Jr., Sachs N, Hamoudi AB, Chiba T et al. Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984; 73: 405-416
26. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 1996; 86: 147-157
27. Peverali FA, D'Esposito M, Acampora D, Bunone G, Negri M, Faiella A et al. Expression of HOX homeogenes in human neuroblastoma cell culture lines. Differentiation 1990; 45: 61-69
28. Merrill RA, Ahrens JM, Kaiser ME, Federhart KS, Poon VY, Clagett-Dame M. All-Trans retinoic acid-responsive genes identified in the human SH-SY5Y neuroblastoma cell line and their regulated expression in the nervous system of early embryos. Biol Chem 2004; 385: 605-614
29. Asgharzadeh S, Pique-Regi R, Sposto R, Wang H, Yang Y, Shimada H et al. Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. J Natl Cancer Inst 2006; 98: 1193-1203
30. Graham A, Papalopulu N, Krumlauf R. The murine and Drosophila homeobox gene complexes have common features of organization and expression. Cell 1989; 57: 367-378
31. Lewis EB. A gene complex controlling segmentation in Drosophila. Nature 1978; 276: 565-570
32. Joshi VV, Cantor AB, Altshuler G, Larkin EW, Neill JS, Shuster JJ et al. Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology Group. Cancer 1992; 69: 2183-2196
33. Chen QR, Bilke S, Wei JS, Whiteford CC, Cenacchi N, Krasnoselsky AL et al. cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-Amplification in neuroblastoma. BMC Genom 2004; 5: 70
34. Coco S, Theissen J, Scaruffi P, Stigliani S, Moretti S, Oberthuer A et al. Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma. Int J Cancer 2012; 131: 1591-1600
35. Spitz R, Oberthuer A, Zapatka M, Brors B, Hero B, Ernestus K et al. Oligonucleotide arraybased comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome. Genes Chromosomes Cancer 2006; 45: 1130-1142
36. Janoueix-Lerosey I, Schleiermacher G, Michels E, Mosseri V, Ribeiro A, Lequin D et al. Overall genomic pattern is a predictor of outcome in neuroblastoma. J Clin Oncol 2009; 27: 1026-1033
37. Yekta S, Tabin CJ, Bartel DP. MicroRNAs in the Hox network: An apparent link to posterior prevalence. Nat Rev Genet 2008; 9: 789-796
38. Gao Z, Ure K, Ding P, Nashaat M, Yuan L, Ma J et al. The master negative regulator REST/ NRSF controls adult neurogenesis by restraining the neurogenic program in quiescent stem cells. J Neurosci 2011; 31: 9772-9786
39. Singh A, Rokes C, Gireud M, Fletcher S, Baumgartner J, Fuller G et al. Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(beta-TRCP) in neuroblastoma cells. Cancer 2011; 117: 5189-5202
40. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11: 1466-1477
41. Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG et al. Localized infant neuroblastomas often show spontaneous regression: Results of the prospective trials NB95-S and NB97. J Clin Oncol 2008; 26: 1504-1510
42. Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM et al. The International Neuroblastoma Risk Group (INRG) classification system: An INRG Task Force report. J Clin Oncol 2009; 27: 289-297
43. Oberthuer A, Juraeva D, Li L, Kahlert Y, Westermann F, Eils R et al. Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients. Pharmacogenomics J 2010; 10: 258-266
44. Zhang B, Schmoyer D, Kirov S, Snoddy J. GOTree Machine (GOTM): A web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinform 2004; 5: 16
45. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002; 99: 6567-6572
46. Vapnik VN. An overview of statistical learning theory. IEEE Trans Neural Netw 1999; 10: 988-999
47. Fischer M, Bauer T, Oberthur A, Hero B, Theissen J, Ehrich M et al. Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q. Oncogene 2009; 29: 865-875
48. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G et al. Integrative genomics viewer. Nat Biotechnol 2011; 29: 24-26
49. Ackermann S, Goeser F, Schulte JH, Schramm A, Ehemann V, Hero B et al. Polo-like kinase 1 is a therapeutic target in high-risk neuroblastoma. Clin Cancer Res 2011; 17: 731-741
50. Kashkar H, Kronke M, Jurgensmeier JM. Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-Induced apoptosis. Cell Death Differ 2002; 9: 750-757
51. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9: 671-675
52. Fischer M, Skowron M, Berthold F. Reliable transcript quantification by real-Time reverse transcriptase-polymerase chain reaction in primary neuroblastoma using normalization to averaged expression levels of the control genes HPRT1 and SDHA. J Mol Diagn 2005; 7: 89-96
53. Ehemann V, Hashemi B, Lange A, Otto HF. Flow cytometric DNA analysis and chromosomal aberrations in malignant glioblastomas. Cancer Lett 1999; 138: 101-106
54. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139: 271-279